Prevalence and clinical features of armadillo repeat-containing 5 mutations carriers in a single center cohort of patients with bilateral adrenal incidentalomas

Eur J Endocrinol. 2023 Aug 2;189(2):242-251. doi: 10.1093/ejendo/lvad088.

Abstract

Objective: We aimed to evaluate the prevalence of armadillo repeat-containing 5 (ARMC5) genetic defects in our cohort of bilateral adrenal incidentaloma (BAI) patients and to evaluate the possible existence of genotype-phenotype correlations.

Design: Cross-sectional study.

Setting: Tertiary care center.

Participants: 72 BAI patients.

Main outcome measure(s): The following data have been collected: morning adrenocorticotropic hormone (ACTH) concentrations; cortisol levels after 1 mg overnight dexamethasone suppression test (F-1mgDST); urinary free cortisol (UFC) levels; diameter of the adrenal masses; and the association with overweight/obesity, arterial hypertension, diabetes mellitus, dyslipidemia, cardiovascular events, unrelated neoplasia, osteoporosis, thyroid nodular disease, and primary hyperparathyroidism. A search for ARMC5 germline and somatic pathogenic variants was performed in all patients and in the adrenal tissue of patients operated on, respectively.

Results: The prevalence of germline ARMC5 pathogenic variants among patients with mild autonomous cortisol secretion (MACS+, defined as F-1mgDST > 1.8 µg/dL) was 18.8%. No germline pathogenic variants were detected in patients without MACS. Moreover, somatic ARMC5 pathogenic variants were also found in the adrenal tissue of six patients without germline ARMC5 variants. The F-1mgDST levels >5 µg/dL predicted with a poor sensitivity but a 90.5% specificity in identifying the presence of ARMC5 germline pathogenic variants. We did not find any clinical parameter predictive of the ARMC5 mutation presence.

Conclusions: In MACS+ BAI patients, germline ARMC5 gene pathogenic variants are frequent. Further studies are needed to elucidate the pathophysiological role of somatic ARMC5 pathogenic variants on adrenal tumor development in otherwise wild-type (WT) patients.

Keywords: adrenal tumors; armadillo repeat-containing 5 (ARMC5); autonomous cortisol secretion; bilateral adrenal incidentaloma; primary bilateral macronodular adrenal hyperplasia (PBMAH).

MeSH terms

  • Adrenal Gland Neoplasms* / epidemiology
  • Adrenal Gland Neoplasms* / genetics
  • Cross-Sectional Studies
  • Humans
  • Hydrocortisone
  • Mutation / genetics
  • Prevalence

Substances

  • Hydrocortisone
  • ARMC5 protein, human

Supplementary concepts

  • Adrenal incidentaloma